Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 17 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact17 DOIs

Deposit reference lists for 13 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact13 DOIs

DOIs for this ISSN

Showing the top 5 of 47 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Physiotherapy rehabilitation in patients with ankylosing spo… (10.4081/br.2019.6)	References ORCID	38.91	5
2	Transthoracic ultrasound versus intraoperative ultrasound in… (10.4081/br.2019.7)	References ORCID	30.10	3
3	Biosimilars: New guns for the treatment of rheumatologic pat… (10.4081/br.2019.3)	References ORCID	23.86	2
4	Monitoring anti-B cell immunotherapies in autoimmune disease… (10.4081/br.2019.26)	References	17.47	4
5	Nutritional aspects of bone health: Not only a matter of vit… (10.4081/br.2019.2)	References ORCID	15.05	1
6	Catastrophic antiphospholipid syndrome: a narrative review (10.4081/br.2019.23)	References ORCID	15.05	1
7	The journey of canakinumab; on- and off-label indications (10.4081/br.2019.4)	References ORCID	15.05	1
8	Breast cancer anti-hormonal therapy and rheumatic diseases:… (10.4081/br.2020.30)	ORCID	11.93	2
9	Buerger’s disease or thromboangiitis obliterans: description… (10.4081/br.2019.21)	References	7.53	1
10	Neridronate in bone marrow edema syndrome. Efficacy and safe… (10.4081/br.2020.34)	ORCID	7.53	1
11	Osteoporosis: prevention and personalized physiotherapy (10.4081/br.2020.36)	ORCID	7.53	1
12	What did COVID-19 do to the organization of Italian rheumato… (10.4081/br.2020.37)	ORCID	7.53	1
13	Kidney involvement in systemic sclerosis (10.4081/br.2019.1)	References ORCID	0.00	0
14	Mediterranean diet and rheumatic diseases (10.4081/br.2019.19)	References ORCID	0.00	0
15	Long-term outcomes in a cohort of patients with juvenile idi… (10.4081/br.2019.25)	References	0.00	0
16	Beyond Rheumatology. A new challenge devoted to the advancem… (10.4081/br.2019.5)	References ORCID	0.00	0
17	Effectiveness and tolerability of focal versus radial extrac… (10.4081/br.2020.11)		0.00	0
18	Effect of hyaluronate and splinting alone <em>versus&l… (10.4081/br.2020.16)		0.00	0
19	Practical approach to vasculitides in adults: an overview of… (10.4081/br.2020.20)		0.00	2
20	Injection therapy in hip osteoarthritis: one year in review (10.4081/br.2020.22)		0.00	0
21	Intra-synovial loose bodies ultrasound-guided removal (10.4081/br.2020.31)		0.00	0
22	Adherence to the Mediterranean diet model and psoriatic dise… (10.4081/br.2020.33)		0.00	1
23	Capsular expansion after ultrasound-guided injection of the… (10.4081/br.2020.35)		0.00	0
24	The evidence of surgery delay after viscosupplementation is… (10.4081/br.2020.38)		0.00	0
25	Therapeutic and functional approach for the treatment of pat… (10.4081/br.2020.39)		0.00	3
26	The COVID-19 war and the battles of rheumatologists (10.4081/br.2020.43)		0.00	0
27	Paget bone disease demonstrated on 18F-fluorocholine PET/CT:… (10.4081/br.2020.44)		0.00	0
28	Interstitial pneumonitis with autoimmune features: 2 case re… (10.4081/br.2020.46)	References	0.00	0
29	EULAR guidelines on ANCA-associated vasculitis in the real l… (10.4081/br.2020.50)		0.00	3
30	Diffuse idiopathic skeletal hyperostosis: a review (10.4081/br.2020.52)		0.00	2
31	When a rheumatologist encounters a Gardner-Diamond syndrome (10.4081/br.2020.53)	ORCID	0.00	0
32	Asymptomatic <em>versus</em> symptomatic patient… (10.4081/br.2021.45)		0.00	1
33	Recurrent ascites in systemic lupus erythematosus treated wi… (10.4081/br.2021.47)		0.00	0
34	The management of large vessel vasculitides (10.4081/br.2021.51)		0.00	0
35	Evaluation of aseptic technique used in interventional rheum… (10.4081/br.2021.54)		0.00	0
36	On- and off-label use of rituximab in rheumatic diseases (10.4081/br.2021.56)		0.00	0
37	RS3PE and the role of ultrasound. A case report and brief re… (10.4081/br.2021.61)		0.00	0
38	Correlation between pain and weakness of vastus medialis eva… (10.4081/br.2021.63)		0.00	1
39	An unusual dyspnea in an 87-year old woman affected by Sjögr… (10.4081/br.2021.64)		0.00	0
40	Rheumatic immune-related adverse events from checkpoint inhi… (10.4081/br.2021.65)		0.00	1
41	Sjögren syndrome diagnosis in a cohort of patients with brea… (10.4081/br.2021.67)	ORCID	0.00	0
42	A case report of calcific aterosclerosis demonstrated on 18-… (10.4081/br.2021.70)		0.00	0
43	Prevalence of osteoporosis and osteoporotic fractures in pos… (10.4081/br.2021.71)		0.00	1
44	Serum calprotectin: emerging marker of rheumatoid arthritis (10.4081/br.2021.73)	ORCID	0.00	0
45	Integration with Spilanthes Achmella in fibromyalgia syndrom… (10.4081/br.2021.74)	ORCID	0.00	0
46	Remitting seronegative symmetrical synovitis with pitting ed… (10.4081/br.2021.76)		0.00	0
47	Treat to target: a winner strategy in rheumatology. From the… (10.4081/br.2021.79)		0.00	0